18th Feb 2008 11:00
AstraZeneca PLC18 February 2008 AstraZeneca PLC appoints new Non-Executive Director AstraZeneca today announced that Jean-Philippe Courtois is to join the Board ofDirectors as a Non-Executive Director with immediate effect. Jean-PhilippeCourtois is currently President of Microsoft International, a territory thatspans 100 subsidiaries operating in over 240 countries outside the United Statesand Canada, and a Senior Vice-President of Microsoft Corporation. Louis Schweitzer, Chairman of AstraZeneca said: "We are very pleased thatJean-Philippe Courtois has agreed to join us. His considerable experience inglobal sales and marketing, including emerging markets, will be of great benefitto the work of the Board". No disclosure obligations arise under paragraph (1) to (6) of Listing Rule9.6.13 of the UK Listing Authority's Listing Rules in respect of the appointmentof Jean-Philippe Courtois. 18 February 2008 Media Enquiries: Steve Brown, +44 207 304 5033 (24 hours)Chris Sampson, +44 20 7304 5130 (24 hours)Neil McCrae, +44 207 304 5045 (24 hours) Investor Enquiries: Jonathan Hunt, +44 207 304 5087Ed Seage, +1 302 886 4065Karl Hard, +44 207 304 5322Jorgen Winroth, +1 212 579 0506Mina Blair, +44 20 7304 5084Peter Vozzo, (MedImmune) +1 301 398 4358 About AstraZeneca AstraZeneca is a major international healthcare business engaged in research,development, manufacturing and marketing of prescription pharmaceuticals andsupplier for healthcare services. AstraZeneca is one of the world's leadingpharmaceutical companies with healthcare sales of US $29.55 billion and is aleader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncologyand infection product sales. AstraZeneca is listed in the Dow JonesSustainability Index (Global) as well as the FTSE4Good Index. - Ends - This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca